Advertisements



vTv Therapeutics Fails Late-Stage Alzheimer"s Study; Is There A Chance For A Comeback?

vTv Therapeutics Fails Late-Stage Alzheimer"s Study; Is There A Chance For A Comeback?.....»»

Category: topSource: seekingalphaApr 16th, 2018

Stifel Sees Challenging Road Ahead For vTv Therapeutics After Failed Alzheimer"s Trial

vTv Therapeutics Inc (NASDAQ: VTVT) announced Monday after the close that results from Part A of its late-stage study of an investigational medication to treat Alzheimer's disease did not m Latest Ratings for VTVT D.....»»

Category: blogSource: benzingaApr 10th, 2018

J&J"s Esketamine Fails to Meet Endpoint in Phase III Study

J&J's (JNJ) late-stage candidate, esketamine nasal spray, fails to show sta.....»»

Category: dealsSource: nyt3 hr. 53 min. ago

Histogenics Slips Below $1 Threshold After Knee Cartilage Candidate Fails Late-Stage Study

Histogenics Corp (NASDAQ: HSGX) shares were losing more than half their market value Wednesday following the release of top-line data from the Phase 3 trial of Neocar read more.....»»

Category: blogSource: benzingaSep 5th, 2018

Why Viking Therapeutics Fatty Liver Study More Than Doubled Shares

Viking Therapeutics shares more than doubled on Tuesday after the company announced results from its mid-stage non-alcoholic fatty liver disease trial......»»

Category: blogSource: 247wallstSep 18th, 2018

Why Viking Therapeutics NAFLD Study More Than Doubled Shares

Viking Therapeutics shares more than doubled on Tuesday after the company announced results from its mid-stage non-alcoholic fatty liver disease trial......»»

Category: blogSource: 247wallstSep 18th, 2018

Why Progenics Shares Are Getting Crushed

Progenics Pharmaceuticals shares dropped on Thursday after the company announced late-stage results from its prostate cancer study......»»

Category: blogSource: 247wallstSep 13th, 2018

Here"s Why Cara Therapeutics Rose 12.5% in August

The company announced second-quarter 2018 earnings results and initiated a crucial late-stage clinical trial......»»

Category: topSource: foxnewsSep 5th, 2018

Glaxo, J&J"s Dual Drug HIV Regimen Succeeds in Phase III Study

Glaxo (GSK) and Johnson and Johnson report positive top line results from a late-stage study of their injectable two-drug regimen for the treatment of HIV. GlaxoSmithKline’s GSK HIV drug subsidiary-ViiV H.....»»

Category: smallbizSource: nytAug 17th, 2018

Roche"s Tecentriq Met Primary Goal in First-Line NSCLC Study

Roche's (RHHBY) late-stage lung cancer study on immuno-oncology drug, Tecentriq, meets its co-primary endpoint of progression-free survival (PFS). Roche H.....»»

Category: dealsSource: nytJul 19th, 2018

Mersana Cries for Mercy

Mersana Therapeutics shares took a massive dive on Thursday morning after the company announced that the FDA put a partial hold on the firm’s early-stage cancer study......»»

Category: blogSource: 247wallstJul 19th, 2018

Pfizer and Eli Lilly Win in Late-Stage Osteoarthitis Study

Pfizer and Eli Lilly shares were largely unaffected after the firms announced positive results from a joint late-stage trial in patients with osteoarthritis pain......»»

Category: blogSource: 247wallstJul 18th, 2018

Celgene and Acceleron Pharma Win Again in Late-Stage Trial

Acceleron Pharma and Celgene each saw a handy gain on Tuesday morning after it was announced results from their late-stage study in adults with transfusion-dependent beta-thalassemia......»»

Category: blogSource: 247wallstJul 10th, 2018

Aquinox Tumbles 82% On Failed Late-Stage Study, But Proof-Of-Concept Trial Might Right The Ship

Aquinox Tumbles 82% On Failed Late-Stage Study, But Proof-Of-Concept Trial Might Right The Ship.....»»

Category: topSource: seekingalphaJul 3rd, 2018

Global Blood Therapeutics shares drop after late-stage data for sickle cell disease treatment

Global Blood Therapeutics Inc. shares dropped as much as 12% in premarket trade on Wednesday after the company reported results for a late-stage trial of sickle cell disease therapy, and said that it met with the U.S. Food and Drug Ad.....»»

Category: topSource: marketwatchJun 27th, 2018

Positive Late-Stage Trial Not Enough to Move the Needle for Pfizer

Pfizer shares slipped slightly on Monday morning after the firm announced results from its late-stage trial of breast cancer. Ultimately the results were positive but not exactly what the study was........»»

Category: blogSource: 247wallstJun 25th, 2018

Sarepta Hits Record High As Duchenne Muscular Dystrophy Gene Therapy Yields Positive Results In Early-Stage Study

Sarepta Therapeutics Inc (NASDAQ: SRPT) shares, halted shortly before Tuesday's open, opened higher by more than 50 percent. read more.....»»

Category: blogSource: benzingaJun 19th, 2018

Teva Fails Late-Stage Trial In Migraine Trial

Teva Fails Late-Stage Trial In Migraine Trial.....»»

Category: topSource: seekingalphaJun 18th, 2018

Eli Lilly, AstraZeneca Drop Two Late-Stage Alzheimer"s Drug Trials

Pharma giants AstraZeneca and Eli Lilly have scrapped two late-stage trials of an experimental Alzheimer’s drug they were co-developing, the latest blow in the long quest to find a breakthrough for the memory-robbing disorder......»»

Category: smallbizSource: wsjJun 12th, 2018

Why Nektar Therapeutics Shares Are Tumbling

Nektar Therapeutics (NASDAQ: NKTR) saw its shares get nearly halved in Monday’s session after the company released preliminary data from its early stage cancer study. The preliminary results........»»

Category: blogSource: 247wallstJun 4th, 2018

AstraZeneca"s Late-Stage Study Win Reinforces Its Hold On Particular Segment Of Lung Cancer Market

AstraZeneca"s Late-Stage Study Win Reinforces Its Hold On Particular Segment Of Lung Cancer Market.....»»

Category: topSource: seekingalphaMay 29th, 2018